Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06060041 · ClinicalTrials.gov registry record
IC-8 Apthera IOL New Enrollment Post Approval Study
A clinical trial of Cataract and Presbyopia, sponsored by Bausch & Lomb Incorporated.
- Recruiting
- Registry status
- 435
- Enrollment target
- 14
- Study locations
NCT06060041: Recruiting study of Cataract and Presbyopia, sponsored by Bausch & Lomb Incorporated.
NCT06060041 is a study of Cataract and Presbyopia that is actively recruiting participants, run by Bausch & Lomb Incorporated. The registered enrollment target is 435 participants, above the 223-participant average among 83 other Cataract trials with a reported enrollment target (95% higher). The trial reports 14 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06060041, a study of Cataract and Presbyopia, is actively recruiting participants, sponsored by Bausch & Lomb Incorporated.
- RECRUITING
- Registry status
- 435 participants
- Enrollment target
- 14
- Study locations
Study Summary
The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation.
Primary Outcome
Rates of additional Nd:YAG laser treatments in the eye implanted with the IC-8 Apthera intraocular lens (IOL) beyond the initial Nd:YAG laser treatment will be assessed through 24 months post IC-8 Apthera IOL implantation
Conditions Studied
Study Locations (14)
Florida
- Argus Research Center - Cape Coral
- Stephenson Eye Associates - Venice
New Jersey
- Eye Associates of New Jersey - Dover
- Northern New Jersey Eye Institute - South Orange
Alabama
- Trinity Research Group, LLC - Dothan
California
- Feinerman Vision Center - Newport Beach
Illinois
- Virdi Eye Clinic and Laser Vision Center - Rock Island
Indiana
- Price Vision Group - Indianapolis
Kansas
- Grene Vision Group - Wichita
Michigan
- Oakland Eye - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 435 participants |
| Start Date | 2023-09-08 |
| Est. Completion | 2027-09-30 |
What NCT06060041 shows while recruiting
NCT06060041 is an observational study that tracks outcomes without assigning an intervention. The registered 435 participants enrollment target is mid-sized for trials with a published cap, above the 223-participant average among 83 other Cataract trials with a reported enrollment target (95% higher).
The record links to 3 conditions, with Cataract appearing as the primary indexed condition, and to 0 interventions.
NCT06060041 lists 14 locations in 12 states (Florida, New Jersey, Alabama).
Frequently Asked Questions
What is clinical trial NCT06060041 about?
NCT06060041 is a clinical study titled "IC-8 Apthera IOL New Enrollment Post Approval Study". The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation.
What is the current status of trial NCT06060041?
This trial is currently recruiting. The enrollment target is 435 participants. The study started on 2023-09-08. Estimated completion is 2027-09-30.
What conditions does trial NCT06060041 study?
This clinical trial studies the following conditions: Cataract, Presbyopia, Posterior Capsule Opacification.
Who is sponsoring clinical trial NCT06060041?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06060041 being conducted?
This trial has 14 study locations across Alabama, California, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06060041's enrollment target sits among peer trials
435 8th of 83 higher than 76 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
RECRUITING
-
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
RECRUITING
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05563220 · 435 participants · Phase 1
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
- NCT07088926 · 435 participants · Phase 2
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
- NCT02622542 · 436 participants · NA
ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy
- NCT05918211 · 436 participants · Phase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI